Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Immunoglobulin Light-chain Amyloidosis 1Amyloidosis 1

Interventions

Dexamethasone 4Whole-Body Irradiation 3Bortezomib 3pomalidomide 2fludarabine phosphate 2daratumumab 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Cyclosporine 2Cyclophosphamide 24-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2venetoclax 1darlin protein, Dictyostelium 1Thiotepa 1Oxycodone 1Music Therapy 1Moxifloxacin 1Morphine 1Methadone 1Melphalan 1Massage 1Hyaluronoglucosaminidase 1Focal Adhesion Protein-Tyrosine Kinases 1Fluorescent Antibody Technique 1Etoposide 1Doxycycline 1Ciprofloxacin 1Carmustine 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Immunoglobulin Light-chain Amyloidosis × Hyaluronoglucosaminidase × Clear all
NCT06376214 2024-04-19

Daratumumab for Patients With Light Chain Amyloidosis

Nanjing University School of Medicine

Phase NA Recruiting
100 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡